SHALENE ESQUERRA: Open Payments
NPI 1841591104 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 20 payments from 5 companies in 2025. Trend: 2023 $313 · 2024 $182 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $188 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Neuronetics, Inc. | 1 | $30 |
| Boston Scientific Corporation | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: VRAYLAR, QULIPTA, Auvelity, NEUROSTAR TMS THERAPY SYSTEM, UBRELVY, WaveWriter Alpha Prime 16, ROTATEQ.
Industry payments across UT — which companies pay providers there.
